Sort by:

• Highly Influential Citations
• Citations
• Acceleration
• Velocity
• Recency

Learn More

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

• Laura Marije Hofstra, Nicolas Sauvageot, +293 authors Ulf Ryding
• Clinical infectious diseases : an official…
• 2016

BACKGROUND Numerous studies have shown that baseline drug resistance patterns may influence the outcome of antiretroviral therapy. Therefore, guidelines recommend drug resistance testing to guide the… (More)

Dynamics of two separate but linked HIV-1 CRF01_AE outbreaks among injection drug users in Stockholm, Sweden, and Helsinki, Finland.

• Helena Skar, Maria Axelsson, +8 authors Jan Albert
• Journal of virology
• 2011

Detailed phylogenetic analyses were performed to characterize an HIV-1 outbreak among injection drug users (IDUs) in Stockholm, Sweden, in 2006. This study investigated the source and dynamics of… (More)

Long-Term Gender-Based Outcomes for Atazanavir/Ritonavir (ATV/r)-Containing Regimens in Treatment-Experienced Patients with HIV

• Veronica Svedhem-Johansson, Pascal Puglièse, +6 authors Maria J. Jimenez-Exposito10
• Current HIV research
• 2013

Clinical data on antiretroviral effectiveness in women are limited, especially long-term data, because women are usually underrepresented in clinical trials. This sub-analysis of a large European… (More)

Prospective Study of Prognostic Factors in Community-Acquired Bacteremic Pneumococcal Disease in 5 Countries

• Mats Kalin, Ake Ortqvist, +11 authors M. A. Woodhead
• The Journal of infectious diseases
• 2000

To define the influence of prognostic factors in patients with community-acquired pneumococcal bacteremia, a 2-year prospective study was performed in 5 centers in Canada, the United States, the… (More)

Streptococcus viridans septicaemia: a comparison study in patients admitted to the departments of infectious diseases and haematology in a university hospital.

• Katarina Westling, Per Ljungman, Anders Thalme, Inger Julander
• Scandinavian journal of infectious diseases
• 2002

Infective endocarditis caused by viridans streptococci is a well-described disease. Streptococcus viridans is also an important etiologic agent causing septicaemia in neutropenic patients with… (More)

Reduced susceptibility to penicillin of viridans group streptococci in the oral cavity of patients with haematological disease.

• Katarina Westling, Inger Julander, Per Ljungman, Anders Heimdahl, Anders Thalme, Carl Erik Nord
• Clinical microbiology and infection : the…
• 2004

The occurrence of oral penicillin-resistant viridans group streptococci (VGS) was studied in 50 patients with either newly diagnosed acute leukaemia or autologous peripheral stem cell transplants.… (More)

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind,…

• Chloe M. Orkin, Edwin Dejesus, +18 authors Huyen L Cao
• The lancet. HIV
• 2017

BACKGROUND Tenofovir alafenamide, a tenofovir prodrug, results in 90% lower tenofovir plasma concentrations than does tenofovir disproxil fumarate, thereby minimising bone and renal risks. We… (More)

Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART.

• Birgitte Stiksrud, Piotr Nowak, +12 authors Marius Trøseid
• Journal of acquired immune deficiency syndromes
• 2015

BACKGROUND Microbial translocation and chronic inflammation may contribute to non-AIDS morbidity in patients with HIV. This study assessed the impact of probiotic intervention on microbial… (More)

Candida albicans tricuspid valve endocarditis in an intravenous drug addict: successful treatment with fluconazole.

• Katarina Westling, Anders Thalme, Inger Julander
• Scandinavian journal of infectious diseases
• 2005

An addicted, intravenous drug user was treated for Candida albicans tricuspid valve endocarditis with high dose fluconazole for 8 months, without relapse after 30 months.

Incidence and outcome of Staphylococcus aureus endocarditis--a 10-year single-centre northern European experience.

• Hilmir Asgeirsson, Anders Thalme, Már Kristjánsson, Ola Weiland
• Clinical microbiology and infection : the…
• 2015

Staphylococcus aureus is a leading cause of infective endocarditis. Little has been published on the outcome and epidemiology of S. aureus endocarditis (SAE) in the twenty-first century. Our aim was… (More)

• ‹
• 1
• 2
• 3
• ›